Lifetime sudden cardiac death risk more than four times higher for those with schizophrenia: Study Dr. Kamal Kant Kohli24 Oct 2024 8:00 AM ISTThe lifetime risk of an unexpected and sudden death from a cardiovascular cause in the absence of pre-existing heart disease-known as sudden cardiac...
Zydus receives USFDA nod for Paliperidone ER Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg MD Bureau Team12 Oct 2024 12:00 PM ISTAhmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received final approval from the...
Obstetric Complications linked to Severe Psychopathology in Schizophrenia Spectrum Disorders, suggests study Medha Baranwal11 Oct 2024 8:00 PM ISTSpain: A recent study published in Neuroscience & Biobehavioral Reviews has revealed that patients with schizophrenia and related disorders who...
USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults Ruchika Sharma29 Sept 2024 10:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY (xanomeline and trospium...
Alembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release Ruchika Sharma27 Sept 2024 4:40 PM ISTMumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Cognitive Decline Increases Risk of Natural Cause Mortality in Schizophrenia, New Study Reveals Medha Baranwal23 Sept 2024 8:00 PM ISTUSA: A recent prospective cohort study published in JAMA Network Open has identified lower cognitive functioning as a significant risk factor for...
Neurocrine halts development of schizophrenia drug luvadaxistat as it fails clinical trial MD Bureau Team13 Sept 2024 3:12 PM ISTLondon: Neurocrine Biosciences said it will halt the development of its experimental drug, aimed at improving cognitive function in patients with...
Traumatic brain injury associated with increased risk of schizophrenia and bipolar disorder, reveals research Dr. Shravani Dali8 Aug 2024 6:30 AM ISTTraumatic brain injury associated with increased risk of schizophrenia and bipolar disorder, suggests a study published in the Psychiatry...
FDA approves long acting extended-release injection for treating Schizophrenia Dr. Kamal Kant Kohli31 July 2024 8:30 PM ISTThe US Food and Drug Administration has approved a new long acting monthly paliperidone palmitate (Erzofri) extended-release injectable suspension...
Long-Term Use of Paliperidone Palmitate Ensures Stability in Schizophrenia patients: JAMA Dr Riya Dave22 July 2024 10:45 PM ISTResearchers in a recent study suggest that 6-monthly paliperidone palmitate sustains stable clinical and functional outcomes long term in adult...
Antipsychotic Drugs may Increase Pneumonia Risk in Schizophrenia Patients, suggests research Jacinthlyn Sylvia13 July 2024 7:45 AM ISTA new study conducted by Jurjen Luykx and team found that antipsychotic medications like olanzapine (>=11 mg/d), quetiapine (>=440 mg/d) and...
DEXA imaging suggests link between schizophrenia and lower BMD and higher rates of fracture: Study Dr. Shravani Dali17 Jun 2024 8:00 AM ISTDEXA imaging suggests a link between schizophrenia and lower BMD and higher rates of fracture suggests a study published in Translational...
